Interpreting the Consequences of Metformin Accumulation in an Emergency Context: Impact of the Time Frame on the Blood Metformin Levels

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Lalau, Jean Daniel ^a,b   Kajbaf, Farshad ^b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; METFORMIN;

ARTERIAL PH; ARTICLE; BLOOD SAMPLING; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; HOSPITAL ADMISSION; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; SYSTEMATIC REVIEW;

EID: 84955750791     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/717198     Document Type: Article

References (12)

1. M. Prikis, E. L. Mesler, V. L. Hood,W. J. Weise, "When a friend can become an enemy! Recognition and management of metformin-associated lactic acidosis," Kidney International, vol. 72, no. 9, pp. 1157-1160, 2007.
2. N. Peters, N. Jay, D. Barraud et al., "Metformin-associated lactic acidosis in an intensive care unit," Critical Care, vol. 12, no. 6, article R149, 2008.
3. J.-D. Lalau, P. Arnouts, A. Sharif, M. E. de Broe, "Metformin and other antidiabetic agents in renal failure patients," Kidney International, 2014.
4. M. R. Gionfriddo, O. L. Morey-Vargas, J. P. Brito, A. L. Leppin, M. H. Murad, V. M. Montori, "Systematic reviews to ascertain the safety of diabetesmedications topical collection on pharmacologic treatment of type 2 diabetes," Current Diabetes Reports, vol. 14, article 478, 2014.
5. M. M. Christensen, C. Brasch-Andersen, H. Green et al., "The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c," Pharmacogenetics and Genomics, vol. 21, no. 12, pp. 837-850, 2011.
6. F. Robert, S. Fendri, L. Hary, C. Lacroix, M.,rejak, J. D. Lalau, "Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects," Diabetes and Metabolism, vol. 29, no. 3, pp. 279-283, 2003.
7. J.-D. Lalau, A.-S. Lemaire-Hurtel, C. Lacroix, "Establishment of a database of metformin plasma concentrations and erythrocyte levels in normal and emergency situations," Clinical Drug Investigation, vol. 31, no. 6, pp. 435-438, 2011.
8. D. Luft, G. Deichsel, R. M. Schmulling, W. Stein, M. Eggstein, "Definition of clinically relevant lactic acidosis in patients with internal diseases,"The American Journal of Clinical Pathology, vol. 80, no. 4, pp. 484-489, 1983.
9. J.-D. Lalau and C. Lacroix, "Measurement of metformin concentration in erythrocytes: Clinical implications," Diabetes, Obesity and Metabolism, vol. 5, no. 2, pp. 92-98, 2003.
10. S. Vecchio and A. Protti, "Metformin-induced lactic acidosis: no one left behind," Critical Care, vol. 15, article 107, 2011.
11. B. A. Mizock and J. L. Falk, "Lactic acidosis in critical illness," Critical Care Medicine, vol. 20, no. 1, pp. 80-93, 1992.
12. F. Kajbaf and J.-D. Lalau, "The prognostic value of blood pH and lactate andmetformin concentrations in severe metforminassociated lactic acidosis," BMC Pharmacology and Toxicology, vol. 14, article 22, 2013.